Digital Core - Enterprise Automation Platform Engineer – RPA Specialty at Eli Lilly and Company

Cork, County Cork, Ireland

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Expertise in specific automation platforms like RPA (Robotic Process Automation)
Expertise in Automation Anywhere Control Room management
Expertise in custom automation frameworks and integrations
Development experience
Ability to work in ambiguity and accept failure
Innovative and curious about new technology to make business processes efficient

Responsibilities

Provide day-to-day technical and platform support for automated systems
Troubleshoot issues related to automation tools, processes, and virtual machines
Ensure smooth operation of automated workflows
Collaborate with development teams to identify and resolve problems
Maintain documentation
Manage upgrades and patching
Monitor automation performance across various systems
Lead operations and lifecycle management projects with global impact (specialty focus on RPA development and lifecycle support from platform to bot level)
Provide technical assistance to end users experiencing problems with automated systems or virtual machines
Explain complex technical concepts and identify root causes of errors within portfolio, as well as upstream or downstream applications

Skills

RPA

Enterprise Automation

Digital Core

Automation Platforms

Robotic Process Automation

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free